The conundrum of personalized cancer management, drug development, and economics.
D003695:Delivery of Health Care / Q000191:economics / Q000379:methods / Q000639:trends; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D054547:National Cancer Institute (U.S.); D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D010548:Personal Health Services / Q000191:economics / Q000379:methods* / Q000639:trends; D010597:Pharmacogenetics / Q000191:economics / Q000379:methods / Q000639:trends; D016499:Radioimmunotherapy / Q000191:economics / Q000379:methods; D011877:Radionuclide Imaging / Q000191:economics / Q000379:methods / Q000639:trends; D019275:Radiopharmaceuticals; D014481:United States
D019275:Radiopharmaceuticals